Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
RYTM: Rhythm Pharmaceuticals, Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
RYTM
The Story
RYTM
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+68.1% / yr
Operating margin
-90.9%
ROIC
-56.4%
Financially safe
Stretched
Debt / equity
1.85×
Interest coverage
-10.0×
Current ratio
4.17×
Rhythm Pharmaceuticals, Inc.
RYTM
NASDAQ Global Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Rhythm Pharmaceuticals, Inc.
RYTM
NASDAQ
·
USD
·
Closed
$99.25
−6.14%
$99.25
−$6.49 (6.14%)
52W Range
52th
pctl
Volume
0.53×
avg
Mkt Cap
6.81B
USD
P/E
-31.7
TTM
Div Yield
–
ann
52W Range
52th
pctl
Volume
0.53×
avg
Market Cap
6.81B
USD
P/E Ratio
-31.7
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings